Why is Shree Ganesh Bio falling/rising?

As of 16-Jul, Shree Ganesh Biotech India Ltd's stock price is currently at Rs 0.82, reflecting a decrease of Rs 0.01 or 1.2%. The stock is trading close to its 52-week low, just 2.44% away from Rs 0.80. It has underperformed its sector by 0.94% today and is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has declined by 4.65%, and its year-to-date performance shows a significant drop of 21.15%. The company is facing operational challenges, with reported operating losses and a weak ability to service its debt, as evidenced by a poor EBIT to Interest ratio of 0.98. Additionally, the stock's return on equity is low at 2.60%, further highlighting its weak profitability.
In the broader market context, the Sensex has shown a decline of only 1.08% over the past week, indicating that Shree Ganesh Biotech is underperforming relative to the benchmark. While the stock has seen a rise in investor participation, with delivery volume increasing by 26.89% against the 5-day average, the overall sentiment remains negative due to the company's financial struggles. The stock's performance over the past year has been particularly poor, with a return of -34.40%, contrasting sharply with the Sensex's gain of 2.38%. This stark difference underscores the challenges facing Shree Ganesh Biotech, contributing to its current downward price movement.